EpiPen price outrage lands Mylan CEO Heather Bresch in Capitol Hill hot seat
02:12
Share this -
copied
Mylan CEO Heather Bresch was in the hot seat on Capitol Hill on Wednesday, citing development costs and middlemen for the soaring price of the company’s EpiPen. Democrats and Republicans alike expressed outrage, with Rep. Elijah Cummings saying the pharmaceutical company has “jacked up the price of a lifesaving product for no discernable reason.” NBC’s Tom Costello reports for TODAY from Washington, D.C.Sept. 22, 2016
UP NEXT
The truth behind ‘buy now, pay later’: Is it boosting your credit?
04:44
Airbnb permanently bans parties for rental bookings
00:40
Hero Boy Scouts speak out after Amtrak derailment in Missouri
02:03
iPhone gets its face time on 15th anniversary of the iconic device
01:29
Why you should start holiday shopping now to get ahead of inflation
02:38
Airlines struggle to keep up with demand ahead of July 4 holiday